Anti-aging Factor GRSF1 Attenuates Cerebral Ischemia-Reperfusion Injury in Mice by Inhibiting GPX4-Mediated Ferroptosis
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
Abnormal accumulation of senescent cells in tissues has been shown to facilitate the onset and progression of various diseases. As an important protein involving in the regulation of cellular senescence process, researches suggested GRSF1 as a potential senolytic target to improve multiple physiological and pathological processes. However, the underlying mechanism of cellular senescence on cerebral ischemia-reperfusion injury (CIRI) has not been revealed. Here, we investigated the effect of GRSF1 on CIRI and delved into its specific mechanisms. In the present study, we established a mouse model of cerebral ischemia-reperfusion (CIR) and observed low expression of anti-aging factor GRSF1, along with greatly increased levels of senescence-related markers p16 and p21 and senescence-associated secretory phenotype TNF-α. Furthermore, we found that the expression of GPX4 was elevated parallel to GRSF1 in CIR mice with overexpression of GRSF1, oxidative stress, and iron metabolism-related proteins were inhibited. Functionally, overexpressing GRSF1 significantly ameliorated infarct volume and neurological function scores and suppressed apoptosis in CIR mice, while administration of GPX4 inhibitors reversed these beneficial phenotypes. Taken together, our results indicate cellular senescence as an important pathological mechanism to exacerbate cerebral injury during CIRI, while GRSF1 could inhibit oxidative stress-mediated ferroptosis through upregulating GPX4 to attenuate reperfusion injury, which makes senolytic treatment, especially GRSF1, a promising therapeutic target for CIRI.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Molecular neurobiology - 61(2024), 4 vom: 26. Apr., Seite 2151-2164 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Yanan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cerebral ischemia-reperfusion injury |
---|
Anmerkungen: |
Date Completed 28.03.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s12035-023-03685-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363542442 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363542442 | ||
003 | DE-627 | ||
005 | 20240401232356.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12035-023-03685-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1359.xml |
035 | |a (DE-627)NLM363542442 | ||
035 | |a (NLM)37861894 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Yanan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-aging Factor GRSF1 Attenuates Cerebral Ischemia-Reperfusion Injury in Mice by Inhibiting GPX4-Mediated Ferroptosis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.03.2024 | ||
500 | |a Date Revised 01.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a Abnormal accumulation of senescent cells in tissues has been shown to facilitate the onset and progression of various diseases. As an important protein involving in the regulation of cellular senescence process, researches suggested GRSF1 as a potential senolytic target to improve multiple physiological and pathological processes. However, the underlying mechanism of cellular senescence on cerebral ischemia-reperfusion injury (CIRI) has not been revealed. Here, we investigated the effect of GRSF1 on CIRI and delved into its specific mechanisms. In the present study, we established a mouse model of cerebral ischemia-reperfusion (CIR) and observed low expression of anti-aging factor GRSF1, along with greatly increased levels of senescence-related markers p16 and p21 and senescence-associated secretory phenotype TNF-α. Furthermore, we found that the expression of GPX4 was elevated parallel to GRSF1 in CIR mice with overexpression of GRSF1, oxidative stress, and iron metabolism-related proteins were inhibited. Functionally, overexpressing GRSF1 significantly ameliorated infarct volume and neurological function scores and suppressed apoptosis in CIR mice, while administration of GPX4 inhibitors reversed these beneficial phenotypes. Taken together, our results indicate cellular senescence as an important pathological mechanism to exacerbate cerebral injury during CIRI, while GRSF1 could inhibit oxidative stress-mediated ferroptosis through upregulating GPX4 to attenuate reperfusion injury, which makes senolytic treatment, especially GRSF1, a promising therapeutic target for CIRI | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cerebral ischemia-reperfusion injury | |
650 | 4 | |a Ferroptosis | |
650 | 4 | |a GPX4 | |
650 | 4 | |a GRSF1 | |
650 | 7 | |a Senotherapeutics |2 NLM | |
650 | 7 | |a Grsf1 protein, mouse |2 NLM | |
650 | 7 | |a glutathione peroxidase 4, mouse |2 NLM | |
650 | 7 | |a EC 1.11.1.9 |2 NLM | |
700 | 1 | |a Shen, Qianni |e verfasserin |4 aut | |
700 | 1 | |a Huang, Lidan |e verfasserin |4 aut | |
700 | 1 | |a Li, Bingyu |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yuxi |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wei |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Bo |e verfasserin |4 aut | |
700 | 1 | |a Gao, Wenwei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular neurobiology |d 1990 |g 61(2024), 4 vom: 26. Apr., Seite 2151-2164 |w (DE-627)NLM012626961 |x 1559-1182 |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2024 |g number:4 |g day:26 |g month:04 |g pages:2151-2164 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12035-023-03685-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2024 |e 4 |b 26 |c 04 |h 2151-2164 |